US FDA NASH: First treatment for fatty liver disease approved
The FDA approves Madrigal Pharmaceuticals Novel Treatment for NASH, Unlocking Potential for a Multibillion Dollar Market (Reuters) – March 14 The first medication to be licenced for non-alcoholic steatohepatitis (NASH),…